Cite
HARVARD Citation
Collins, M. (2018). Burosumab: At Long Last, an Effective Treatment for FGF23‐Associated Hypophosphatemia. Journal of bone and mineral research. pp. 1381-1382. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Collins, M. (2018). Burosumab: At Long Last, an Effective Treatment for FGF23‐Associated Hypophosphatemia. Journal of bone and mineral research. pp. 1381-1382. [Online].